Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02345252
Brief Title: Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)

First Submitted : January 19, 2015
First Submitted that Met QC Criteria : January 19, 2015
First Posted : January 26, 2015 (Estimate)

Results First Submitted : September 20, 2017
Results First Submitted that Met QC Criteria : November 7, 2017
Results First Posted : December 8, 2017

Certification/Extension First Submitted : February 14, 2017
Certification/Extension First Submitted that Met QC Criteria : February 14, 2017
Certification/Extension First Posted : February 16, 2017

Last Update Submitted that Met QC Criteria : December 16, 2019
Last Update Posted : January 2, 2020